Thus, CCL19, SELL and VCAM-1 may not be sequential activation of a single pathway, but rather synergize through different mechanisms such as chemotaxis, adhesion and barrier modulation to drive the inflammatory response and pathological injury in Bell’s palsy. Here, CCL19 is linked to Bell's palsy.